Showing results (1161-1170 of 1,887) with videos related to

Sort By:
Pageof 189
Endokrynologia Polska|November 4, 2009
[Chromogranin A (CgA) - characteristic of the currently available laboratory methods and conditions which can influence the results]Piotr Glinicki, Wojciech Jeske
Endokrynologia Polska|October 10, 2025
Controlled attenuation parameter is associated with metabolic disorders in patients with obesity in the Chinese populationJiaqi Chen, Shihui Lei, Aijie Huang, et al.
Endokrynologia Polska|June 30, 2025
Inappropriate antidiuretic hormone secretion syndrome following COVID-19 infection misdiagnosed as cerebral infarctionYi Li, Jianbin Wei, Chengdian Lan, et al.
Endokrynologia Polska|June 30, 2025
Adrenocortical carcinoma during pregnancyMarta Klepinowska, Elżbieta Sowińska-Przepiera, Elżbieta Andrysiak-Mamos, et al.
Endokrynologia Polska|June 30, 2025
Calcitonin and procalcitonin measurement after cholecystokinin-2/gastrin receptor agonist stimulation in patients with advanced medullary thyroid cancer: results from the GRAN-T-MTC studyMałgorzata Trofimiuk-Müldner, Katica Bajuk Studen, Paola Anna Erba, et al.
Endokrynologia Polska|June 30, 2025
Sex differences in the prevalence and profile of metabolic syndrome: results of a screening program from Western Mexico in self-appointed healthy adultsGabriel Fermin Trigueros-Del Valle, Alberto Tlacuilo-Parra, Edgar Alfonso Rivera-León, et al.
Endokrynologia Polska|June 30, 2025
Primary hepatic neuroendocrine carcinoma coexisting with atypical lung adenocarcinomaLiang Yin, Yangyang Lin, Tianlei Kou, et al.
Endokrynologia Polska|June 30, 2025
Estrogenic endocrine disruptors and cancer: a narrative reviewSara Julietta Lozano-Herrera, Nataly García-Gutiérrez, Ana Gabriela Hernández-Puga, et al.
Endokrynologia Polska|June 30, 2025
Selective androgen receptor modulators (SARMs) - potential anabolic drugs for the treatment of cachexia and frailty syndromeRafał Borecki, Piotr Byczkiewicz, Jolanta Słowikowska-Hilczer
Endokrynologia Polska|May 7, 2025
The associations between skeletal muscle mass to visceral fat area ratio (SVR) with bone mineral density (BMD) and 10-year probability of fracture risk in Chinese patients with type 2 diabetes mellitus (T2DM): a cross-sectional studyYuning Guo, Renxuan Li, Na Xu, et al.
Pageof 189